surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) PDF] Early-Onset Type 2 Diabetes
Pay in 4 interest-free payments of $5.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) PDF] Early-Onset Type 2 Diabetes](https://figures.semanticscholar.org/47f2cbae01360a57626762aec4a9f115ff7b6417/6-Figure1-1.png)
![surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) PDF] Early-Onset Type 2 Diabetes](https://www.uspharmacist.com/CMSImagesContent/2022/Tirzepatide-T1.gif)
![surpass 6 tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) PDF] Early-Onset Type 2 Diabetes](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-023-01797-5/MediaObjects/12933_2023_1797_Fig1_HTML.png)

























